Glenmark Pharma Launches Ryaltris Nasal Spray for Allergic Rhinitis in US Market
US arm of Glenmark Pharmaceuticals has launched the fixed-dose combination (FDC) therapy for seasonal allergic rhinitis in the US market. This Ryaltris nasal spray will...